CRMDCorMedix Inc.
What is the market doing?
No clear lean: nothing decisive, though a crowded short (+20% of shares).
Choppy, but holding above its 200-day average. Price is +2% vs its 200-day average.
A crowded short, settled Sep 30, 2026, more than a week of normal trading to cover, a crowded exit.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How CRMD is trading
CorMedix Inc. is −30% over the past year while the S&P 500 is +16%: 46 points behind the market.
1-year return · S&P 500 +16%
- vs 200-day average
- +2.3%
vs 200-day average · close to trend
- RSI (14)
- 68
RSI (14) · neutral
- Below its 52-week high
- 38%
Below its 52-week high
Details›
- Last close2026-10-23
- $7.84
- 1 monthS&P 500 −0.94%
- +0.97%
- 1 yearS&P 500 +16%
- −30%
- 5 yearsS&P 500 +86%
- +58%
- vs 50-day average$7.85
- −0.12%
- 52-week high
- $12.73
- 52-week low
- $6.25
- Annualised volatility
- 73%
| Year | Return |
|---|---|
| 2026 (year to date) | −33% |
| 2025 | +44% |
| 2024 | +115% |
| 2023 | −11% |
| 2022 | −7.3% |
| 2021 | −39% |
| 2020 | +2.1% |
| 2019 | +13% |
| 2018 | +158% |
| 2017 | −67% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 5 of 10 | +3.1% |
| Feb | 10 | 5 of 10 | +4.3% |
| Mar | 10 | 4 of 10 | −12% |
| Apr | 10 | 6 of 10 | +2.8% |
| May | 10 | 4 of 10 | −3.7% |
| Jun | 10 | 6 of 10 | +7.2% |
| Jul | 11 | 5 of 11 | +10% |
| Aug | 11 | 8 of 11 | +8.8% |
| Sep | 11 | 5 of 11 | +4.1% |
| Oct | 11 | 6 of 11 | +0.05% |
| Nov | 10 | 6 of 10 | +12% |
| Dec | 10 | 4 of 10 | −1.6% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Where the price stands
Its trend against the 50-day and 200-day averages, and the levels it keeps coming back to.
What it has returned
With dividends, year by year, month by month, and by calendar month on average.